We have investigated chemically modified DNFs capable of enhanced binding to HER2+ cancer cells, hypothesising that functionalising the surface of a DNF with a HER2 targeting aptamer (25) might improve its interaction with HER2+ cells due to cooperativity. The gene discussed is ERBB2; the disease is cancer.